98
Views
42
CrossRef citations to date
0
Altmetric
Original Research

Proportion and risk indicators of nonadherence to antihypertensive therapy: a meta-analysis

&
Pages 211-218 | Published online: 13 Feb 2014

References

  • World Health OrganizationAdherence to Long-Term Therapies: Evidence for ActionGenevaWHO2003
  • LawMRMorrisJKWaldNJUse of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studiesBMJ2009338b166519454737
  • HaynesRBYaoXDeganiAKripalaniSGargAMcDonaldHPInterventions for enhancing medication adherenceCochrane Database Syst Rev2005CD00001116235271
  • CutlerDMEverettWThinking outside the pillbox – medication adherence as a priority for health care reformN Engl J Med20103621553155520375400
  • LemstraMBlackburnDFCrawleyAFungRProportion and risk indicators of non-adherence to statin therapy: a meta-analysisCan J Cardiol201228557458022884278
  • Eze-NiliamCMThombsBDLimaBBSmithCGZiegelsteinRCThe association of depression with adherence to antihypertensive medications: a systematic reviewJ Hypertension20102817851795
  • KronishIMWoodwardMSergieZOgedegbeGFalzonLMannDMMeta-analysis: impact of drug class on adherence to antihypertensivesCirculation20111231611162121464050
  • PetersonAMNauDPCramerJABennerJGwadry-SridharFNicholMA checklist for medication compliance and persistence studies using retrospective databasesValue Health20071031217261111
  • MotheralBBrooksJClarkMAA checklist for retrospective database studies – report of the ISPOR task force on retrospective databasesValue Health20036909712641858
  • AlsabbaghWLemstraMEurichDSocioeconomic Status and Non Adherence to Anti-Hypertensive Drugs: A Systematic Review and Meta-AnalysisValue in Health2014 Available from: http://www.ispor.org/publications/value/articlesinpress.aspAccessed February 4, 2014
  • DouglasGAPractical Statistics for Medical Research1st edNew YorkChapman and Hall1991
  • FleissJlThe statistical basis of meta-analysisStat Methods Med Res199321211458261254
  • Huedo-MedinaTBSánchez-MecaJMarín-MartínezFBotellaJAssessing heterogeneity in meta-analysis: Q statistic or I2 index?Psychol Methods20061119320616784338
  • HigginsJPGreenSCochrane Handbook for Systematic Reviews of InterventionsChichester, UKJohn Wiley & Sons2006
  • DerSimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials198671771883802833
  • RasmussenJNChongAAlterDARelationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarctionJAMA200729717718617213401
  • SetoguchiSChoudhryNKLevinRShrankWHWinkelmayerWCTemporal trends in adherence to cardiovascular medications in elderly patients after hospitalization for heart failureClin Pharmacol Ther20108854855420827266
  • MonaneMBohnRLGurwitzJHGlynnRJLevinRAvornJThe effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderlyAm J Hypertens1997106977049234822
  • BloomBSContinuation of initial antihypertensive medication after 1 year of therapyClin Ther1998206716819737827
  • Degli EspostiLDegli EspostiEValpianiGA retrospective, population-based analysis of persistence with antihypertensive drug therapy in primary care practice in ItalyClin Ther20022413471357 discussion 134612240784
  • YangYThumulaVPacePFBanahanBF3rdWilkinNELobbWBPredictors of medication nonadherence among patients with diabetes in Medicare part D programs: a retrospective cohort studyClin Ther20093121782188 discussion 2150–215119922889
  • ShayaFTDuDGbarayorCMFrech-TamasFLauHWeirMRPredictors of compliance with antihypertensive therapy in a high-risk Medicaid populationJ Natl Med Assoc2009101343919245070
  • ElliottWJPlauschinatCASkrepnekGHGauseDPersistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapiesJ Am Board Fam Med200720728017204738
  • PerreaultSLamarreDBlaisLPersistence with treatment in newly treated middle-aged patients with essential hypertensionAnn Pharmacother2005391401140816076920
  • TairaDAGelberRPDavisJGronleyKChungRSSetoTBAntihypertensive adherence and drug class among Asian Pacific AmericansEthn Health20071226528117454100
  • van WijkBLShrankWHKlungelOHSchneeweissSBrookhartMAAvornJA cross-national study of the persistence of antihypertensive medication use in the elderlyJ Hypertens20082614515318090552
  • LambDEurichDMcAlisterFChanges in adherence to evidence-based medications in the first year after initial hospitalization for heart failure: observational cohort study from 1994 to 2003Circ Cardiovasc Qual Outcomes2009222823520031842
  • GogovorADragomirASavoieMPerreaultSComparison of persistence rates with angiotensin-converting enzyme inhibitors used in secondary and primary prevention of cardiovascular diseaseValue Health20071043144117888108
  • SiegelDLopezJMeierJAntihypertensive medication adherence in the Department of Veterans AffairsAm J Med2007120263217208076
  • FriedmanOMcAlisterFAYunLCampbellNRTuKAntihypertensive drug persistence and compliance among newly treated elderly hypertensives in OntarioAm J Med201012317318120103027
  • CorraoGZambonAParodiADo socioeconomic disparities affect accessing and keeping antihypertensive drug therapy? Evidence from an Italian population-based studyJ Hum Hypertens20092323824418668127
  • EagleKAKline-RogersEGoodmanSGAdherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational studyAm J Med2004117738115234641
  • WogenJKreilickCALivorneseRCYokoyamaKFrechFPatient adherence with amlodipine, lisinopril, or valsartan therapy in a usual-care settingJ Manag Care Pharm2009942442914613440
  • YangYThumulaVPacePFBanahanBF3rdWilkinNELobbWBNonadherence to angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers among high-risk patients with diabetes in Medicare part D programsJ Am Pharm Assoc201050527531
  • KramerJMHammillBAnstromKJNational evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insuranceAm Heart J2006152454e1e816923412
  • Degli EspostiESturaniADi MartinoMLong-term persistence with antihypertensive drugs in new patientsJ Hum Hypertens20021643944412037702
  • WongMCJiangJYSuXWangHTangJLGriffithsSMIndividuals at risk of beta-blocker discontinuation: a cohort study in 19,177 Chinese patientsClin Res Cardiol20109927728420174812
  • SungSKLeeSGLeeKSKimDSKimKHKimKYFirst-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims reviewClin Ther2009311309132019695396
  • EvansCDEurichDTRemillardAJShevchukYMBlackburnDFirst-fill medication discontinuations and nonadherence to antihypertensive therapy: an observational studyAm J Hypertens20122519520322089108
  • RasmussenJNGislasonGHRasmussenSUse of statins and beta-blockers after acute myocardial infarction according to income and educationJ Epidemiol Community Health2007611091109718000133
  • CarraoGParodiAZambonAReduced discontinuation of anti-hypertensive therapy by two-drug combination as first step. Evidence from daily life practiceJ Hypertens2010281584159020543716
  • World Health OrganizationICD-10: International Statistical Classification of Diseases and Related Health ProblemsNew YorkWHO2008
  • EvansCDEurichDTLuXRemillardAJShevchukYMBlackburnDThe association between market availability and adherence to antihypertensive medications: an observational studyAm J Hypertens20132618019023382402
  • Canadian Pharmacists AssociationCompendium of Pharmaceuticals and Specialties: Thiazide Diuretics – Product MonographOttawaCanadian Pharmacists Association2012
  • DiMatteoMRLepperHSCroghanTWDepression is a risk factor for noncompliance with medical treatment: a meta-analysis of the effects of anxiety and depression on patient adherenceArch Intern Med20001602101210710904452
  • OsterbergLBlaschkeTAdherence to medicationN Engl J Med200535348749716079372
  • O’MalleyASForrestCBMandelblattJAdherence of low-income women to cancer screening recommendationsJ Gen Intern Med20021714415411841530
  • CelanoMGellerRJPhillipsKMZimanRTreatment adherence among low-income children with asthmaJ Pediatr Psychol1998233453499824922
  • OrlandiMAPromoting health and preventing disease in health care settings: an analysis of barriersPrev Med1987161191303823010
  • DiamondJGuns, Germs, and Steel: The Fates of Human SocietiesNew YorkWW Norton1999
  • US Census BureauPeople below poverty level and below 125 percent of poverty level by race and Hispanic origin: 1980 to 2009–2012 Available from: http://www.census.gov/compendia/statab/2012/tables/12s0711.pdfAccessed January 24, 2013